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Over the past 3 years, transcatheter extraction of arterial rates substantially lower than the rates obtained with surgery. 
plaque has evolved as our alternative treatment for sympto- A more aggressive approach with catheter extraction of 
matic peripheral vascular disease. At~erectomy catheters atheroma and risk factor management may allow a group of 
are designed to remove obstructive thrombus or atheroma, patients with even mildly disabling claudication to once again 
but should not produce a full-thickness endarterectomy in resume full walking capabihty. Atherectomy, a percutaneous 
most cases (l-3). For short, simple lesions, complete endar- catheter-directed approach to treatment, may provide a more 
terectomy may be possible. favorable risk/benefit ratio than that provided by surgery. 
Patients without limb-threatening or socioeconomically 
disabling claudication have traditionally been treated with 
risk factor control and an exercise program, because of the 
significant morbidity and mortahty associated with vascular 
surgical procedures and the lack of long-term symptomatic 
relief with balloon angioplasty. For conservative therapy to 
be abandoned, more aggressive therapy will have to provide 
long-lasting symptomatic relief and morbidity and mortality 
Patients with severe and extensive atherosclerosis caus- 
ing rest pain or limb-threatening ischemia are candidates for 
surgical treatment of peripheral vascular disease. A select 
group of these patients may also be candidates for percuta- 
neous atherectomy, thereby avoiding or delaying the need 
for bypass surgery. 
The adjuncvive use of intraarterial urokinase converts 
many complicated (thrombus and plaque) long segment OC- 
elusions to segmental stenotic lesions that can more easily be 
treated with atherectomy (4-6). Although this approach is 
more complicated, it preserves the native artery, which in 
many cases may be adequate and possibly superior to the 
bypass graft. 
Although the future treatment of atherosclerotic disease 
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Table 1. Clinical Patient Chamteristics by Lesion GrOUP Table 2. Ankle/Brachial Index in 112 Patients 
Male/female ratio 
Age (yr) 
Mean 
Range 
Medical history 
Smokers (active) 
Diabetes mellitus 
Hypertension 
Previous myocardial 
infarction 
Total cholesterol 
>2SO mg/dl 
HDL cholesterol 
~30 mg/dl in men 
~40 mgldl in women 
Symptoms 
Claudication 
>2 blocks 
s2 blocks 
Ischemic rest pain 
-..- 
Simple 
(n == 28) 
1816 
66 
324% 
12 (43%) 
6 (21%) 
9 (3?%) I 
8 (29%) 
I6 (57%) 
9 (32%) 
I9 (68%) 
0 
Lesion Group 
Complex 
(n = 84) 
63121 
61 
41-72 
IO (12%) 
38 (45%) 
42 (50%) 
34 (40%) 
32 (38%) 
0 
a4 (Km%) 
34 (40%) 
Overall 
(n = 112) 
lSl37 
62 
32-96 
22 (20%) 
44 (39%) 
51(460/o) 
42 (38%) 
48 (43%) 
6 
57 (76%) 
a (22%) 
9 (8%) 
103 (92%) 
34 (30%) 
Atherectomy 
Last 
Lesion Group Pre Post Pollow-up 
Simple 0.48 + 0.25 0.80 2 18 0.78Z 
Complex 0.32 r O.l8* 0.67 + 32 0.64 * 22 
*Maximal index 0.39; minimal index 0.14; range 0.39-o. 14. 
multiple segmental stenoses with >75% diameter narrowing 
without evidence of occhrsion, irrespective of length of the 
stenosis, or both. A complex lesion was defined as I) a >5 
cm occlusion, 2) multiple segments of occlusion totaling >5 
cm, or 3) single or multiple segmental occlusions as de- 
scribed, with additional areas of stenotic but nonoccluded 
disease. There *=* -,rele 28 patients in the group with a simple 
lesion and $4 in the group with a complex lesion. All patients 
had the atherectomy performed in the superficial femoral or 
the popliteal artery, or both. 
Sixteen patients underwent thrombolysis with urokinase 
before atherectomy (2 in the simple group and 14 in the 
complex group). In 8 of the 16, the lesion was converted 
from complex to simple, and atherectomy of only a stenotic 
lesion was required. These eight patients were subsequently 
classified in the simple group despite their initial presenta- 
tion with a complex lesion. 
HDL = high density lipoprotein. 
may lie in risk factor reduction and prevention, current 
therapy must focus on interventional techniques to restore 
blood flow by removing or remodeling plaque and on throm- 
bolytic agents to allow reopening of affected arteries for 
catheter-directed treatments (1). As techniques and devices 
improve, these interventions will become more able to 
increase runoff in smaller arteries of the lower limb and 
thereby enhance patency rates in procedures in the more 
proximal vessels such as the superficial femoral or popliteal 
arteries. In this report, we review our experience using 
percutaneous atherectomy alone or with thrombolysis. 
Study patients. Between October 1987 and April 1989, 
112 patients were successfully treated with atherectomy 
alone or in combination with thrombolysis with urokinase 
(Abbokinase, Abbott Laboratories) (Table 1). Of the patients 
entered into this study, 6 were treated with an IVT trans- 
luminal extraction catheter (TEC Interventional Vascular 
Technologies), and the remaining 106 were treated with the 
Simpson AtheroCath (Devices for Vascular Intervention). 
All patients had symptomatic occlusive peripheral arterial 
disease with ischemic discomfort at rest, ulceration or exer- 
cise-induced claudication. 
ClassI6eatIon of lesions and procedures. Lesions were 
classified as simple or complex. A simple lesion was defined 
as Ii a single segmental occiusion 55 cm, or 2) single or 
After atherectomy with the Simpson AtheroCath, only 
~20% angiographic residual stenosis was considered suc- 
cessful. With the IVT device, successful treatment included 
a 50% reduction in the angiographic stenotic luminal diam- 
eter. Four additional patients had a procedure failure (4 
[3.4%] of 116) and wzre not considered in this analysis. In 
three obese patients, we were unable to pass the atherec- 
tomy device carriage through the groin into the common 
femoral artery; in one patient, the procedure was stopped 
because the patient became uncooperative. 
Foiiow-up studies. All patients had noninvasive segmen- 
tal arterial pressure studies and plethysmography before and 
after treatment (Table 2) (7,8). Patients were followed up at 
1,3,6, 12 and 24 months with repeat anklehrachial indexes, 
segmental pressures and plethysmography. In addition, all 
patients had duplex ultrasound examination of the segment 
treated by the atherectomy catheter (Fig. 1) (Ultra-Mark 8, 
Advanced Technologies Laboratory). These scans were 
performed before atherectomy and at 3, 12 and 24 months 
after the procedure. Complete angiography was performed 
in all patients before and immediately after atherectomy. 
Atherectomy procedure. Arteriograms and atherectomy 
were performed by using an anterograde approach to the 
common femoral artery cannulation. In patients requiring 
urokinase therapy before atherectomy, the thrombolytic 
therapy catheter was placed from the contralateral common 
femoral artery using a 5F sheath and an end-hole catheter. 
Urokinase was delivered to the clot with the catheter em- 
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1. Ultrasound examination and spectral anal- 
the superticial femoral and popliteal arteries 
were used to confirm anatomic stenosis and evaluate 
the hemedynamic sig cance of the arterial segment 
before (A) and after 
with the real time image provided an accurate deter- 
mination of the severity of the stenotic lesion that 
was intended for treatment (A). Angiography was 
used to confirm duplex ultrasound findings. After 
atherectomy, resolution of the stenotic lesio 
B-mode recording and the presence of Norman 
sic Doppler flow were good indicators of re 
normal hemodynamic function in the treated arterial 
). Restenosis did not occur in patients 
who had evidence of normal triphasic Doppler flow 
at the immediate postatherectomy study and the I 
month evaluation. 
bedded within the clot. The technique for t~rombolysis was 
similar to that reported by McNamara and Fischer (4). After 
complete angiography with numeric marking, the initial 5F 
sheath for angiography was replaced with the appropriate 
sheath for the atherectomy catheters; 7F and 9F sheaths 
were used for the 7F and 9F atherectomy catheters, respec- 
tively. For all total occlusions, crossing of the occlusion was 
performed in a standard fashion using a variety of guide 
wires. After crossing the lesion, the 5F end-hole catheter 
was passed over the guide wire to create a channel for 
passage of the atherectomy catheter. After completion of the 
procedme and reversal of anticoagulant therapy, the sheaths 
were removed and manual pressure was applied to the 
arterial entry site for 20 to 30 min. All arteriograms were 
performed in the cardiac catheterization laboratory with 
cineangiography. In all patients, pressure measurements 
were obtained proximal and distal to the intended segment of 
treatment before and after atherecto 
e- and pastmediation and ~h~orn~o~ys~” Medications 
administered before, during and after atherectomy were 
identical in all patients. Pretreatment of all patients began 
with aspirin (650 mg), usually given the night before the 
procedure or 4 h before the procedure in a few patients. 
Administration of dipyridamole (75 mg, three times daily) 
was begun the day of the procedure. The atherectomy 
procedure began with insertion of an introducer sheath and 
administration of 5,000 to 10,000 U heparin intraarterially. 
Those in the complex group received 10,000 U heparin and 
those in the simple group had 5,000 U heparin. Arteriogra- 
phy was performed using nonionic contrast medium with 20 
U heparinll ml of contrast medium. Completion angiography 
was obtained in all p;&nts. All patients were treated with a 
natural triglyceride dsh oil concentrate (MaxEPA, six cap 
sules daily), beginrling the day after treatment. 
When urokina,,-e was administered before the atherec- 
tomy procedure, a 5F end-hole catheter was inserted through 
a 5F sheath irom the contralateral groin in 15 of the 16 
patients and from the ipsilateral groin in 1. Urokinase was 
administered at a rate of 4,000 Ulmin until anterograde Bow 
was obtained; the dose was then reduced to 2,000 Ulmin. 
Infusion duration ranged from 2 to 28 h (mean I lb. Monitor- 
ing of the thrombin time and fibrinogen was done before 
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infusion ad at 12 h intervals during the infusion. A continu- 
ous heparin flush (200 to 500 U/h, mean 400) through the 
sheath was used in ah of the patients who received urokinase. 
In two patients, urokinase was administered for an additional 
6 h after the atherectomy to lyse residual thrombus in the 
region of the atherectomy and distal native arteries. 
me a&edmy catheters. The six candidates for the 
IvT atherectomy catheter were chosen at the discretion of 
the investigators. In all six patients, this catheter was 
introduced through a sheath placed anterograde in the com- 
mon femoral artery ipsilateral to the lesion intended for 
treatment. Using an external centimeter marker ruler placed 
before angiography, the catheter was positioned in the 
region of the intended atherectomy. In the six patients, both 
7F and 9F catheters were used sequentially with a central 
guide wire passed across the lesion. The catheter was slowly 
advanced while rotating the cutter blade and aspirating 
through the central lumen. After completed passage of the 
smaller sized catheter, the next huger size was introduced 
until a 9F (3 mm) cutting device could be used. In four of the 
six IVT catheter atherectomies, residual stenosis required 
completion atherectomy using a 9F Simpson AtheroCath. In 
one patient, the atherectomy achieved with the IVT system 
was adequate, and in one patient balloon angioplasty of the 
residual stenosis was necessary. 
The Simpson AtheroCath was advanced into the lesion 
using the marker ruler for guidance. Balloon inflations of 1, 
2 and 3 atm were done sequentially. Two to four passes of 
the cutter blade were performed in each arterial quadrant 
undergoing atherectomy. Forty-five to 90” rotations of the 
catheter housing were performed to produce circumferential 
tissue extraction. When the collection chamber was filled, 
the catheter system was removed and the collection chamber 
cleared of atheromatous debris. The catheter was then 
reinserted for further atherectomy. 
All specimens retrieved with the Simpson AtheroCath 
were fixed in buffered formalin and sent for pathologic 
examination. Samples removed with the IVT device were 
too small to be adequately evaluated pathologically. 
MnitIon of success. Successful atherectomy was defined 
as the removal of a sign&ant amount of plaque or athero- 
matow debris, including thrombus, to restore flow through 
the artery with <20% residual stenosis. In addition, the 
patient must have improved clinically as indicated by healing 
of ischemic ulcerations or improvement in segmental pres- 
SUM across the region of treatment, or both. An increase in 
anklehachial index also indicated improved limb perfusion. 
The clinical status of the patient, segmental Doppler pres- 
sures, at&k/f~RChi~ index and plethysmographic recordings 
were checked at follow-up examinations. If restenosis oc- 
curred, retreatment with atherectomy was performed and 
the Patient was then considered to have continued success. 
B&B~J~ of eomplieations. A major complication was 
defined as any episode that required transfusion or surgical 
Table 3. Earlv and Late Results* of Atherectomv in 112 Patients 
Lesion Group 
Simple 
(n = 28) 
Complex 
(n = 84) 
Initial results Is30 days) 
Success 28 (100%) 18 (93%) 
Failure 0 6 (7%) 
Late results (mean 12 months)t 
Success 26 (93%) 67 (80%)$ 
Failure 2 (7.1%) 17 (20%) 
*See text fcr definitions of success. tFollow-up range 5 to 24 months. 
*Represents the number of patients with initial success (n = 78) who were 
considered to hare continued success at late follow-up evaluation (cumulative 
success rate). 
intervention to correct a problem directly related to the 
atherectomy or thrombolytic procedure. In addition, any 
complication associated with the procedure that occurred 
within 30 days of the procedure was included as a procedural 
complication. An example of this would be the development 
of a false aneurysm. Acute reocclusion of the treated arterial 
segment was considered a failure of therapy. Embolism as a 
result of atherectomy was also considered a major compli- 
cation. 
Early aad late success rates (Table 3). Atherectomy was 
performed in 128 arteries in the 112 patients. There were 28 
patients with a simple lesion and 84 with a complex lesion. 
Eighty-eight atherectomies were performed in the femoro- 
popliteal arterial segment, 8 in the popliteal artery only and 
16 in the superficial femoral artery only. Results are reported 
in terms of patients undergoing atherectomy rather than 
numbers of arteries. Therefore, if a patient underwent bilat- 
eral atherectomy, a “success” required successful treatment 
of both arteries rather than a single artery. All 28 patients 
with a simple lesion treated by atherectomy had an initial 
success and 2 (7.1%) had restenosis at 12 months. In the 
complex group, 78 (93%) of 84 patients had initial success (30 
day patency) and an additional 11 patients (14%) had re- 
stenosis at 12 months. The duration of the follow-up period 
ranged from 5 to 24 months (mean 12). 
Angiographic findings. All 28 patients with a simple le- 
sion treated by atherectomy had at least a parent single tibia1 
vessel that entered the foot. In the group with a compiex 
lesion, 70 of the 84 patients had at least one patent tibia! 
vessel to the level of the foot, although 4 of these patients 
had a severely diseased vessel with >70% stenosis in at least 
one area of the sole vessel providing outflow to the foot. 
Fourteen patients had no contiguous tibia1 vessel flow distal 
to the popliteal artery, and flow to the foot was solely 
through collateral vessels. 
Four of the six patients in the complex group with initial 
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considered successes at 
attempt. Pathologic s 
erosclerosis or a 
media identified. 
Crf the remaining seven patients who had restenosis 
without repeat atherectomy, four h 
three had restenosis with a patent artery. All four patients 
with an occluded artery had occlusion at the time of the 
initial atherectomy and the initial clinical status of two of the 
four had worsened. Three of the four patients had surgical 
revascuiarization. One patient continued on conservative 
therapy. The remaining three patients with a stenotic but 
patent artery are continuing on conservative therapy; all 
three patients have significant cardiac disease. 
After urokinase treatment, 10 patients had simple lesions 
(2 patients initially with simple lesions and 8 additional 
patients who were in the complex group and were converted 
to the simple lesion group), which ail remained patent at a 
mean follow-up period of 14 months (Fig. 2). Six patients in 
the complex group who continued to have a complex lesion 
after treatment with urokinase had initially successful 
atherectomy; one patient exhibited failure at 12 months (94% 
success). 
The six patients with a simple lesion treated by IVT 
atherectomy are included in the preceding results. Ail at- 
tempts were initially successful; two of the six patients 
exhibited failure at a mean follow-up period of 11 months. 
The two failures included one patient who received baboon 
dngiopiasty after IVT cathekr atherectomy, and the second 
patient was considered a primary successful treatment with 
the IVT system alone and had no subsequent procedure. 
In two of the six patients who had IVT catheter atherec- 
tomy, embolism was noted. One large e 
and anterior tibia1 bifurcation was manually extracted using a 
9F g~idjng catheter, and atheromatous skin lesions were 
noted in a second patient the day after the procedure. The 
skin lesions subsequently healed without further treatment. 
No additional complications were noted at the follow-up 
study. Ail I12 patients were seen at least twice gn follow-up 
examinations. Ninety-two (82%) of the 112 patients were 
examined on three occasions and 20 (18%) were seen on two 
occasions. 
s. Percutaneous trans- 
primary procedure in 
patients to avoid the morbidity associated with a vascular 
surgical procedure. The superiority of angioplasty over by 
pass procedures has not been established, and its immediate 
success rate a long-term effectiveness have been ques- 
ost clinical reports of angiopiasty iuciude 
ide range of clinical 
success of angiopiasty is the result of the balloon catheter 
reshaping the artery or redistributing plaque. 
recem study, Blair et al. (9) demonstrated that in patients with 
critical arterial ischemia and threatened limb loss (such as tht 
patients with a complex lesion treated with atherectomy in 
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Figure 2. Occlusion of the superficial femoral artery at the adductor 
canal documented by angiography (A). Delayed films demonstrated 
an isolated popliteal artery segment (II). There was no evidence of a 
contiguous artery patent from the adductor canal area to the tibial 
arteries before urokinase infusion. After urokinase, patency of the 
superficial femoral and popliteai arteries was easily identified, 
disclosing a short stenotic lesion in the midpopliteal artery (C) that 
was easily treated with a 9F atherectomy device (D). This demon- 
strates conversion of a complex, mainly thrombotic lesion to a 
simple atherosclerotic lesion. 
our study), the 2 year patency rate after angioplasty was only 
I$%, signiicantly lower than that of femoropop!iteal bypass 
(68%) or femorotibial bypass (47%) at the same institution. 
These results for angioplasty are admittedly poorer than those 
of many previously reported series of femoropopliteal angio- 
plasty, but others (10,ll) report results that include patients 
with claudication as well as with threatened limb loss. These 
reports of treating less critically ischemic patients demon- 
strate long-term patency rates of 50% to 80%. 
The low patency rate with angioplasty and the need for 
subsequent procedures to achieve limb salvage in the study 
by Blair et al. (9) clearly indicate that angioplasty is not a 
durable procedure for infrainguinal atherosclerotic disease 
that is producing limb-threatening ischemia. Glover et al. 
(10) reported a limb salvage rate of 71% when angioplasty 
was combined with a bypass procedure, but only 34% limb 
sa!vage from angioplasty alone. In a later study, Borozan et 
al. (11) reported inferior long-term results, whereas in a 
randomized trial compxing angioplasty with surgery, Wil- 
son Ed al. (12) concluded that each therapy produced equally 
durable results. It should be understood that the conclusions 
of Wilson et at. (12) may not apply to patients with severe 
with HDL cholesterol < 
cation of systemic athero 
presence of a history of 
of our patients. 
constituted 22%. An irndi- 
The disease in this study group s-itould also be considered 
rehtively severe; 103 patients (92%) of the group had symp- 
toms of claudication after waking for two blocks or less. 
Ischemic rest pain was present in 34, constituting 30% of the 
overall group of 40% of the complex lesion group. 
Long=Ee results. Although the numbers in this study 
are smail, simple atherectomy in the superkia! femoral and 
poplitea! segment appears to have a durable 1 year result. In 
addition, compared with balloon angioplasty, the complex 
lesion group in our study had an exceedingly durable result. 
These results rival those of femoropopliteal bypass grafting, 
which would be the traditional form of therapy for this 
group. Perhaps technical considerations or the inability lo 
cross the obstructed lesions would be the on’.jr limitation for 
proceeding with atherectomy. Although it was not speciii- 
tally addressed in this study, combining a surgical procedure 
after failure of atherectomy does not seem to be precluded. 
We emphasize the importance of strict attention to reduction 
of lumina! stenosis to <20%. In fact, in 40% of our patients, 
the treated portion of the &ery had a greater lumina! 
diameter than the artery proximal to this area. The remaining 
I stemis versus no 
group was procedure related 
procedure while she was hemodyoamica~ly stable; the sub- 
ty was a direct res of the infarction. 
nw;~se. The careful rn~~istr~tio~ of uroki- 
nase in con~unct~o~ with atherectomy in our patien 
not seem to lead to additional complications. Careful 
selection and ~~a~erne~t cf tk i?fusicn catheter 
contralateral common femoral artery are important te~~~~c~ 
considerations. Experience with i~tr~~eria! tbr~rnbo!yt~~ 
infusions to reopen occluded peripheral arteries is extensive 
(4-6, 13-16). Theoretic advantages of using urokinase in this 
setting include removal of thrombus, which may be a nidus 
for restenosis if left within the artery. Also, in many patients 
a long segmental occlusion may be reduced to 
focal stenotic lesion after urokinase infusion. 
obviously provide the patient with a shorter 
procedure and a better long-term result, as reflected in our 
data. Whenever thrombus is suspected and it is safe to 
administer a thrombolytic agent, we recommend first clear- 
ing the artery of thrombus before proceeding with the 
atherectomy. This approach has resulted in highly successful 
and safe reopening of occluded arteries. 
Ciinica! irn~!ic~~!~~s. The study was not designed to 
evaluate costs. It is our impression that savings associated 
with a catheter”directed therapy are at times overstated. ln 
some cases, a surgica! procedcre is avoided, wkich 
result in cost savings, reduced disability and salvage of the 
native artery. Other considerations arise as to the selection 
of patients for arherectomy who may not otbe~ise have 
been considered for surgical revasculari~~tion. 
a!!e! comparison of balloon angioplasty versus atherectomy 
indicates that atherectomy is a more durable procedure and 
can be accomp!ished with a high degree of success and with 
procedural technical capabilities equal to those of angio- 
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plasty (g-11). It is likely that differences may exist between 
our patients and those reported in angioplasty studies. 
Nonetheless, our patients are comparable to most patients 
with vascular disease considered for treatment. In fact, the 
indications for treatment, length and location of lesions and 
severity of disease in the complex atherectomy group are 
comparable with those in most surgical reports. 
Conclusions. Femoropopliteal atherectomy has a very 
high rate of success and low morbidity and mortality rates; it 
may be a good alternative to the conservative approach for 
the mildly symptomatic patient. For the patient with a 
complex, more diffuse diseased arterial lesion, with rest pain 
and limb-threatening ischemia, atherectomy provides a more 
promising alternative to percutaneous transluminal angio- 
p&y and a very competitive ahemative to surgery. Tech- 
nical considerations for atherectomy may be complex, but 
treatment can be successfully accomplished in the vast 
majority of patients. Arterial occlusion does not preclude 
therapy with atherectomy devices and, in our experience, 
the Simpson AtheroCath has been the most successful 
device. Close follow-up study is imperative for these pa- 
tients, and the planning of treatment in conjunction with 
vascular surgical colleagues must be considered. 
Because of the high restenosis rate associated with bal- 
loon angioplasty, atherectomy in our group of patients is 
considered the most appropriate treatment when a catheter- 
directed therapy is indicated. A direct comparison of results 
between atherectomy and femoropopliteai bypass grafting 
was not made in this study. Further evaluaticq of atherec- 
tomy in comparison with surgical intervention &>ppears war- 
ranted. 
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